Assignee
SHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD
CN·4 granted patents·2 citations·filing 2016–2022
Top patents by PatentIndex Score
4 records- 0178US9867803B2IRE-1α inhibitorsSHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD·Filed 2017·Granted Jan 16, 2018·2 cites·28 claims
- 0251US12577253B25,6-dihydrothieno[3,4-h]quinazoline compoundSHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD·Filed 2022·Granted Mar 17, 2026·0 cites·13 claims
- 0351US9856266B2IRE-1alpha inhibitorsSHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD·Filed 2016·Granted Jan 2, 2018·0 cites·17 claims
- 0448US12459940B2Oxazole compound as multi-targeted inhibitor of IRAK4 and BTKSHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD·Filed 2020·Granted Nov 4, 2025·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI FOSUN PHARMACEUTICAL IND DEVELOPMENT CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →